TAK-003: development of a tetravalent dengue vaccine
Introduction Dengue incidence has increased over the past few decades. One tetravalent dengue vaccine based on a yellow fever backbone has been approved, but due to increased risk of severe disease in dengue-naïve recipients, its use is limited to individuals with prior dengue exposure.Areas covered...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2025-12-01
|
| Serija: | Expert Review of Vaccines |
| Teme: | |
| Online dostop: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2490295 |
| Oznake: |
Brez oznak, prvi označite!
|